SAN DIEGO, April 18 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical company, announced today that Joseph M. Limber, President and Chief Executive Officer, will present a company overview at the UBS Global Specialty Pharmaceuticals Conference. The presentation is scheduled for 9:30 a.m. Eastern Time, Tuesday, April 25, 2006 at the Grand Hyatt New York.
Interested parties can access a live audio web cast of the presentation at www.prometheuslabs.com. A replay of the presentation will be available at the same location.
Prometheus Laboratories Inc. is a specialty pharmaceutical company committed to developing new ways to help physicians individualize patient care. Prometheus focuses on the treatment, diagnosis and detection of gastrointestinal, autoimmune and inflammatory diseases and disorders. Prometheus’ strategy includes the marketing and delivery of pharmaceutical products complemented by its proprietary, high-value diagnostic testing services. By integrating therapeutics and diagnostic services, Prometheus addresses the continuum of patient care, thereby providing physicians with a comprehensive solution to treat chronic diseases. Prometheus’ corporate offices are located in San Diego, California. Additional information about Prometheus can be found at www.prometheuslabs.com .
Prometheus Laboratories Inc.
CONTACT: Beth Kriegel, Senior Director, Finance and Investor Relations ofPrometheus Laboratories Inc., +1-858-410-2516
Web site: http://www.prometheuslabs.com/
